Navigation Links
St. Jude scientist named Howard Hughes Medical Institute investigator
Date:5/9/2013

Michael Dyer, Ph.D., a scientist at St. Jude Children's Research Hospital, has been selected as a Howard Hughes Medical Institute (HHMI) investigator. Dyer is one of 27 scientists nationwide chosen for the recognition from among 1,155 applicants. There are approximately 330 HHMI investigators in the United States, and Dyer will become the third of these investigators currently working at St. Jude.

Investigators selected for the program by HHMI are some of the country's top biomedical researchers, demonstrating creativity, innovative and excellence in their areas of study. Dyer is an expert in the fields of developmental neurobiology, cell cycle regulation, stem cell biology, developmental therapeutics and cancer genetics.

"Dr. Dyer's research has repeatedly overturned long-held beliefs in science, earning him great respect as a world-class scientist and as an innovator," said Dr. William E. Evans, St. Jude director and CEO. "Being selected as an HHMI investigator is a great honor for any scientist, and the additional funding it provides will accelerate Dr. Dyer's research and the impact he is having on the treatment of childhood cancers."

Dyer's contributions include a 2007 study that showed brain cells called neurons could still divide. The finding countered a century-old scientific belief that differentiated, or mature, nerve cells could not multiply and make new cells. In 2012, Dyer and his colleagues demonstrated that an unexpected mechanism was responsible for the rapid growth of an eye tumor called retinoblastoma.

Dyer is a member of the St. Jude Developmental Neurobiology department and co-leader of the Developmental Therapeutics for Solid Malignancies Program. He is also an investigator with the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, an effort to decode the genomes of childhood cancer patients and identify the genetic missteps that lead to disease.

Through the HHMI Investigator Program, scientists are provided salary, benefits and a research budget during their initial five-year appointment. The initiative represents an investment in basic biomedical research of approximately $150 million. This year's groups of investigators hail from 19 institutions and represent a variety of scientific disciplines.

Dyer joined the St. Jude faculty in 2002 and quickly emerged as a leader in the study of retinoblastoma. He has received numerous honors and awards, including the 2008 Cogan Award from the Association for Research in Vision and Ophthalmology, a Career Development Award from Research to Prevent Blindness, as well as that organization's Lew R. Wasserman Merit Award. Dyer was also selected as a Pew Scholar in the Biomedical Sciences and was named an HHMI Early Career Scientist. He received his doctoral degree in molecular and cellular biology from Harvard University and completed his postdoctoral training at Harvard Medical School.

Dyer joins St. Jude researchers Charles Sherr, M.D., Ph.D., and Brenda Schulman, Ph.D., in holding HHMI investigator designations. The new HHMI investigators begin their appointments in September 2013.


'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Related biology news :

1. Salk scientists find potential therapeutic target for Cushings disease
2. American Chemical Society resource connects scientists, discoveries, chemistry & biology interface
3. Scientists alarmed by rapid spread of Brown Streak Disease in cassava
4. Scientists discover how brains auditory center transmits information for decisions, actions
5. Scientists discover new way protein degradation is regulated
6. Europe needs genetically engineered crops, scientists say
7. Scientists awarded $5.5 million for wheat, rice blast research
8. Huddersfield scientist helps to reveal a link in the evolutionary chain
9. Study led by NUS scientists reveals escalating cost of forest conservation
10. Scientists map all possible drug-like chemical compounds
11. Scientists find ethnicity linked to antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer ... that they have entered into a multiyear collaboration to identify and characterize novel ... additional tools for gene editing across all applications. , Under the terms of ...
(Date:10/12/2017)... ... 12, 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK ... module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants ... sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market will ...
(Date:10/12/2017)... Diego, CA (PRWEB) , ... ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically ... all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
Breaking Biology Technology: